Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.64 HKD | +2.66% | +0.55% | -51.04% |
Jun. 03 | ImmuneOnco Biopharmaceuticals Gets China's Phase 3 Trial Approval for Leukemia Drug | MT |
May. 30 | ImmuneOnco Completes Filing with China Regulator for Conversion of H Shares | MT |
- Stock Market
- Equities
- 1541 Stock
- News ImmuneOnco Biopharmaceuticals (Shanghai) Inc.